Substance Use Disorders
416
70
98
239
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
83 trials with published results (20%)
Research Maturity
239 completed trials (57% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.4%
14 terminated out of 416 trials
94.5%
+7.9% vs benchmark
5%
19 trials in Phase 3/4
35%
83 of 239 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 239 completed trials
Clinical Trials (416)
Harnessing Telemedicine to Improve Alcohol Use Disorder Outcomes in Primary Care Patients
Characterization of Phenotypic and Genotypic Regressors for Imaging
DEVELOPMENT OF A NOVEL PEER RECOVERY SUPPORTER TRAINING PLATFORM
Shared Decision Making to Treat Or Prevent (STOP) HIV in Criminal Legal Involved Populations (R33)
Evaluation of the Safety and Effects of Psychoactive Substances in People With Past Opioid Use
tAN for Substance Use Disorder
rTMS for Craving in Methamphetamine Use Disorder
Supporting Treatment Access and Recovery in Re-entry (STAR-R)
Safe & Sound Protocol in Adults With Trauma and SUD
Ketamine for Methamphetamine Use Disorder
Physical Activity as Adjunct Treatment for Opioid Substitution Therapy
Recovery Inspired Support Engagement (RISE) Pilot
Enhancing Prospective Thinking in Early Recovery (PARK)
Temporal Interference Methods for Addiction Treatment
Development and Evaluation of a Virtual Reality Tool for At-Risk Trauma-Exposed Young People
Intervention for Comorbid Substance Use and Bipolar Disorders
Enhancing Substance Use Treatment Services to Decrease Dropout and Improve Outpatient Treatment Utilization in Emerging Adults
STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for Smoking
Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation
Enhancing Prospective Thinking in Early Recovery